Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03629093
Other study ID # GENIUS
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 1, 2021
Est. completion date December 30, 2024

Study information

Verified date February 2021
Source Huashan Hospital
Contact Xiao-Yu Yang, M.D.
Phone 52889999
Email yangxiaoyu@huashan.org.cn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Numerous preclinical evidence has confirmed that most commonly-used general anesthetics can affect neurodevelopment of young animals adversely, causing both structural defect of brain and cognitive impairment. However, it is unclear at present whether such effect would also occur to children exposed to general anesthesia in their early life. Several observational clinical studies and one interventional clinical trial indicated that short-time general anesthesia less than 80 minutes might be safe to cognitive development. Concerning long-time and/or multiple anesthesia exposure, some studies supported its association with long-term cognitive defects, while other studies did not. These studies are mainly retrospective or ambirectional researches. We have designed a prospective, multicenter cohort study to examine the neurodevelopment of infants exposed to anesthesia before age 2 in the first year after surgery, and compare the neurodevelopment status of infants exposed to anesthesia less than 3 hours and those more than 3 hours. The Gesell Developmental Inventory (GDI) and several neuropsychological testing batteries will be used. The anticipated outcome of the study will add reliable evidence from Asians to elucidate the relationship of anesthesia and long-term neurodevelopment of infants.


Recruitment information / eligibility

Status Recruiting
Enrollment 1000
Est. completion date December 30, 2024
Est. primary completion date September 30, 2024
Accepts healthy volunteers No
Gender All
Age group N/A to 2 Years
Eligibility Inclusion Criteria: - Apgar score = 8 at birth - ASA level ?~? - Obtained written consent form from the infants' parents or guardians Exclusion Criteria: - Postmenstrual age = 44 weeks, or postmenstrual age = 144 weeks - Severe cardiac, pulmonary, or neurologic disease - Severe obstructive sleep apnea hypopnea syndrome - History of dystocia and/or hypoxic ischemic encephalopathy - Gestational age at birth =32 weeks - Any known or suspected chromosomal abnormalities, abnormal development of vision or hearing, neurodevelopment retardation, or other known acquired or congenital abnormalities that might affect neurodevelopment - Significant cardiovascular surgery, significant ENT surgery, or neurosurgery - Malignant diseases that may reduce survival - Taking part in other clinical trials in the last 3 months or at present

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
General Anesthetics
General anesthesia required for surgery procedures or diagnostic interventions using either intravenous or inhalation anesthetics, or both.

Locations

Country Name City State
China Huashan Hospital Fudan University Shanghai Shanghai

Sponsors (6)

Lead Sponsor Collaborator
Huashan Hospital Children's Hospital of Fudan University, Shanghai Children's Hospital, Shanghai Children's Medical Center, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Country where clinical trial is conducted

China, 

References & Publications (4)

Davidson AJ, Disma N, de Graaff JC, Withington DE, Dorris L, Bell G, Stargatt R, Bellinger DC, Schuster T, Arnup SJ, Hardy P, Hunt RW, Takagi MJ, Giribaldi G, Hartmann PL, Salvo I, Morton NS, von Ungern Sternberg BS, Locatelli BG, Wilton N, Lynn A, Thomas JJ, Polaner D, Bagshaw O, Szmuk P, Absalom AR, Frawley G, Berde C, Ormond GD, Marmor J, McCann ME; GAS consortium. Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trial. Lancet. 2016 Jan 16;387(10015):239-50. doi: 10.1016/S0140-6736(15)00608-X. Epub 2015 Nov 4. Erratum in: Lancet. 2016 Jan 16;387(10015):228. — View Citation

Graham MR. Clinical update regarding general anesthesia-associated neurotoxicity in infants and children. Curr Opin Anaesthesiol. 2017 Dec;30(6):682-687. doi: 10.1097/ACO.0000000000000520. Review. — View Citation

Sun LS, Li G, Miller TL, Salorio C, Byrne MW, Bellinger DC, Ing C, Park R, Radcliffe J, Hays SR, DiMaggio CJ, Cooper TJ, Rauh V, Maxwell LG, Youn A, McGowan FX. Association Between a Single General Anesthesia Exposure Before Age 36 Months and Neurocognitive Outcomes in Later Childhood. JAMA. 2016 Jun 7;315(21):2312-20. doi: 10.1001/jama.2016.6967. — View Citation

Warner DO, Zaccariello MJ, Katusic SK, Schroeder DR, Hanson AC, Schulte PJ, Buenvenida SL, Gleich SJ, Wilder RT, Sprung J, Hu D, Voigt RG, Paule MG, Chelonis JJ, Flick RP. Neuropsychological and Behavioral Outcomes after Exposure of Young Children to Procedures Requiring General Anesthesia: The Mayo Anesthesia Safety in Kids (MASK) Study. Anesthesiology. 2018 Jul;129(1):89-105. doi: 10.1097/ALN.0000000000002232. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change of the developmental quotient of the Gesell Developmental Inventory The Gesell Developmental Inventory has been translated into Chinese and standardized by the Beijing Children's Health Care Institute and the performance results are expressed as a developmental quotient (DQ). From baseline before anesthesia to 1 year after anesthesia
Secondary Change of the standardized score of the five domains of the Gesell Developmental Inventory The five behavioral domains are gross motor, fine motor, language, adaptive, and personal-social behaviors. From baseline before anesthesia to 1 year after anesthesia
Secondary Change of the standardized score of the Social Maturity Scale The Social Maturity Scale includes six domains and 132 questions designed to be completed by the parents. From baseline before anesthesia to 1 year after anesthesia
See also
  Status Clinical Trial Phase
Completed NCT01162798 - Preterm Infant Growth N/A
Completed NCT00808756 - Study on Fermentable Carbohydrates in Healthy Infants N/A
Completed NCT00355654 - Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both Are Co-Administered With Prevenar® Phase 3
Recruiting NCT06032494 - Investigating Changes in Vital Signs in Neonates
Not yet recruiting NCT05914324 - Outpatient Pediatric Pulse Oximeters in Africa N/A
Completed NCT04523441 - Early Support and Physiotherapy for Children and Their Motor Skills
Completed NCT02441296 - Carbohydrate and Metabolism: a Pilot Study N/A
Completed NCT01216709 - Iron Absorption From Infant Formula and Iron Drops in Infants (MJAU-studien) N/A
Completed NCT00507676 - Lung Function and Structure in Healthy Infants and Infants With Recurrent Wheezing N/A
Recruiting NCT05072626 - High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia
Completed NCT04536194 - Dopamine Versus Norepinephrine Under General Anesthesia Phase 3
Recruiting NCT04598061 - IV Dexmedetomidine as Spinal Anesthesia Adjuvant in Infants
Completed NCT03567031 - Impact of CO2 on Cerebral Blood Flow in Infants Less Than 6 Months During General Anaesthesia N/A
Completed NCT02366780 - Breast Milk Content Expressed Manually Compared to Electric Pump N/A
Terminated NCT04641000 - The Alberta BLOOM Long Term Follow Up Study
Completed NCT02580123 - Smile-Kids: Study on Complementary Feeding Transition N/A
Completed NCT00294294 - Study Evaluating Treatment of Fever in Children Who Have Been Vaccinated With Prevenar and Infanrix Hexa Phase 4
Recruiting NCT04967118 - Neonatal Pain Management and Pain Monitoring Using New Methods N/A
Completed NCT03025178 - Optimal Insertion Depth of Left Internal Jugular Vein Catheter in Infants N/A
Completed NCT02722759 - Haemoglobin Measurement for Babies N/A